Get to know our advisors.

Michael Breault


Michael Breault is CEO of Circles, the world’s largest concierge provider. A seven-year company veteran, Mr. Breault was named President of Circles at the completion of its acquisition by Sodexo in October 2007, and became CEO in 2009. Over the past few years, Mr. Breault led the company’s global expansion into the United Kingdom, France, Brussels, Luxembourg, and Sweden. He continues to spearhead the company’s international growth. As part of Mr. Breault’s unwavering commitment to create a global concierge platform that delivers consistent and familiar service to clients’ customers worldwide, he acquired and integrated new business models keeping concierge on the forefront of innovation. Mr. Breault oversaw the firm’s proprietary knowledge management initiative, which was uniquely designed to reinforce the link between emerging technology, superior customer experience and local expertise. This continuously developed technology, created interfaces that dynamically redefined the interactions between a client, their customers and their employees. This ultimately drove brand advocacy. Prior to joining Circles, Mr. Breault served as Director, Vice President - Global Cross Marketing at Citigroup. He identified new revenue opportunities for Citigroup's business units by leveraging the existing customer base. Previously, he was the North American Brand Manager for British Airway’s Concorde, First and Business Class and led their loyalty program, British Airways Executive Club. Prior to British Airways, Mr. Breault worked for Young & Rubicam.

Michael J. Doyle

Medsphere Systems

Mr. Doyle is President and Chief Executive Officer of Medsphere Systems Corporation. He is an entrepreneur and Chief Executive Officer who has excelled at creating value for investors in healthcare and technology. Mr. Doyle joined Medsphere in October 2007 after serving as President and CEO of Advantedge Healthcare Solutions, a New York-based Software as a Service (SaaS) outsourced physician-billing company backed by private equity investors. From 2000 to 2004, Mr. Doyle served as Chairman and CEO of Salesnet, one of three pioneering global enterprise software providers that established the SaaS customer relationship market. In 1989 Mr. Doyle founded The Standish Care Company, a provider of assisted living and long-term care services. As Chairman and CEO, he built the company organically, and in 1992 guided it through the first successful initial public offering (IPO) for an assisted-living service provider. A series of mergers and acquisitions in the years that followed resulted in the 1996 merger of Standish with Carematrix. After the merger, Mr. Doyle served as CEO of the combined companies, which retained the Carematrix name. Mr. Doyle's efforts ultimately yielded a highly successful organization with a market capitalization in excess of $500 million. In his career, Mr. Doyle has held senior management positions at Voluntary Hospitals of America and at Tenet Healthcare Corporation's predecessor National Medical Enterprises. He received a bachelor of science in biology with a minor in community health from Tufts University. He also received an MBA with a focus on healthcare and finance from the University of Chicago, where he was a Kaiser Fellow.

David A. Galardi, Pharm.D.


Dr. Galardi currently leads the commercial operations practice of the company he co-founded, Apogenics, Inc., a diversified healthcare company servicing the orthopedic, biologic and specialty healthcare markets. Before forming Apogenics, he was Vice President of Corporate Development at the AmerisourceBergen Specialty Group (ABSG), a distributor of specialty pharmaceuticals and services to the physician specialist and specialty pharmaceutical markets. He was responsible for bringing the many brands of ABSG to the pharmaceutical and specialty physician marketplaces in a strategic fashion by growing the business from $600 million in revenue to greater than $9 billion over that period. He was an integral part of the success of the ABSG oncology franchise. Before this role, Dr. Galardi was Director of Trade Development for Bergen Brunswig Drug Company (BBDC) where he developed strategies and represented BBDC to the manufacturer community at the senior and executive levels. Dr. Galardi worked for Aetna as Regional Product Director and for Prudential HealthCare as Director, National Programs and Director, Business Development. After he received both a Bachelors and a Doctorate in Pharmacy from the Philadelphia College of Pharmacy and Science, Dr. Galardi trained at both the University of Pennsylvania Medical Center and the Hospital of the University of Pennsylvania. Dr. Galardi also graduated from the Outcomes Institute Program at the University of South Carolina and from the Management Development Program in Healthcare at the University of Southern California Graduate School of Management.

Scott D. Hayworth, M.D., FACOG

Mount Kisco Medical Group

Dr. Hayworth has been President and Chief Executive Officer of the Mount Kisco Medical Group (MKMG), a 205-physician multispecialty medical group, since 1996. Dr. Hayworth is also the Chairman-Elect of the American Medical Group Association. Prior to joining MKMG in 1988, he was Chief Resident in Obstetrics and Gynecology, Mount Sinai Hospital. Dr. Hayworth is also a Clinical Assistant Professor of Obstetrics, Gynecology, and Reproductive Sciences at Mount Sinai School of Medicine. In addition, he is Head of the Board of Directors of the Ambulatory Surgery Center of Westchester; a member of the Foundation Board of Northern Westchester Hospital; President and a member of the Board of Directors of Bedford Physicans' Risk Retention Group; and a consultant for Vincent Memorial Obstetrics & Gynecology Service, Massachusetts General Hospital. His many other organizational leadership roles include being Chairman for District II of the American College of Obstetrics and Gynecology and a member of ACOG's national executive board; and serving as one of nine physicians on the national advisory board for Aetna Insurance. Dr. Hayworth received his A.B. in Biology from Princeton and received his M.D. from Cornell University Medical College in 1984. He is a Consulting Editor for Contemporary OB/GYN, and his writings have been published in various medically-related magazines. Honors include “Best Doctor” listings in New York and Westchester magazines, the Best Doctors in America publication, and America's Top Obstetricians and Gynecologists. Dr. Hayworth was the 2002 recipient of the American College of Obstetricians and Gynecologists District Service Award.

David E. Kroin

Great Point Partners

Mr. Kroin co-founded Great Point Partners, an investment firm exclusively investing in growth health care companies, in 2003. Great Point manages over $400 million for leading financial institutions, endowments and high net worth families. Mr. Kroin serves on the Investment Committee for both the private and public equity funds managed by Great Point. Mr. Kroin currently serves as a Director on the Boards of APT Pharmaceuticals, Inc., Biodel, Inc. (NASD: BIOD), Caprion Proteomics Inc. and Risk Services Corporation. He was previously a Board Member of US Bioservices Corp. (acquired by AmerisourceBergen), Gentium Spa. (NASD: GENT), Icon International Inc. (acquired by Omnicom), and several other companies. Prior to founding Great Point Partners, Mr. Kroin was a partner in J.H. Whitney & Co. funds and a senior member of its health care group. He began his career as an investment banker in mergers and acquisitions at Merrill Lynch & Company. He graduated from the University of Michigan with a B.S. in actuarial mathematics.

Richard Toren


Mr. Toren serves President and Chairman of the Board of CodeRyte, Inc. Prior to joining CodeRyte, Mr. Toren founded a physician practice management firm (Promedco, Inc.) in 1983 that was sold to Vivra Specialty Partners in 1996. Following this acquisition, he served for two years as president of Vivra Heart Services (VHS). VHS acquired cardiology practices, provided management services and received specialty capitated contracts from payers to deliver care through a network model. VHS had more than 400 employees and 65 physicians when Mr. Toren left to join CodeRyte. He also spent two years running a pharmacovigilance data firm, which a venture firm aimed to turn around. While managing physician practices, Mr. Toren purchased LabCorp, a clinical laboratory located in Pennsylvania, for $1.3 million and then successfully sold the company for $6.4 million to National HealthLabs, the largest clinical laboratory company in the country. From 1970 to 1983, Mr. Toren was vice president of marketing and sales for Survival Technology Inc., an R&D technology company that commercialized products and sold royalty rights to medical device companies. While there, Mr. Toren invented the EpiPen, as well as several other valuable products. Survival Technology’s royalty revenues grew from zero to $25 million in 10 years. Mr. Toren assisted the American College of Cardiology with HCFA in rulemaking for reimbursement of overhead costs associated with operating a physician practice. He also served as vice-chairman of the American Heart Association Nation’s Capital Affiliate and president of the Ronald McDonald House. Mr. Toren currently serves on the board of the American Heart Association for Greater Washington, D.C. and on its parent board, the Mid-Atlantic Affiliate, as well as for Christiana Care Health in Wilmington, Del. In his spare time, he enjoys lecturing about entrepreneurship in local high schools, Georgetown and American Universities. Mr. Toren received his undergraduate degree at Pennsylvania State University and attended the Loyola Graduate School of Business MBA program for two years.

Steven Zirkel

Varolii Corporation

Mr. Steven Zirkel is one of the founding executives of Varolii Corporation where he currently serves as Vice President and General Manager. In his current capacity, Mr. Zirkel leads a team driving sales and business development operations. The team’s charter is to produce growth while delivering high value relationships to industry leaders like Medco, Aetna, Bank of America, Delta and Progressive Insurance. His healthcare experience started in 2004 where he co-initiated the Healthcare Industry Group at Varolii, the group that established partnerships with Medco, Cigna, Aetna, Heathway’s and Partners Healthcare. The healthcare segment is now comprised of four specific solution offerings and partnerships with over 40 payers, providers and disease management entities. With over 23 years of CRM and contact center industry experience, Mr. Zirkel’s expertise lies at the intersection of technology, ROI and user experience. Prior to Varolii, Mr. Zirkel managed sales and consulting businesses for world-class organizations including Aspect, Siemens and IBM. Mr. Zirkel graduated from Albany University with a BA in Communications.